CBT101

Dodecyl Creatine Ester · Ceres Brain Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CBT101, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Intranasal Administration of Dodecyl Creatine Ester (CBT101) in Healthy Male Subjects [Phase 1]